Cargando…
Nephrogenic Systemic Fibrosis Risk and Liver Disease
Objective. Evaluate the incidence of nephrogenic systemic fibrosis (NSF) in patients with liver disease in the peritransplant period. Materials and Methods. This IRB approved study retrospectively reviewed patients requiring transplantation for cirrhosis, hepatocellular carcinoma (HCC), or both from...
Autores principales: | Hanna, Robert F., Finkelstone, Lee A., Chow, Daniel S., Miloushev, Vesselin Z., Escudero, Mark R., Lagana, Stephen M., Prince, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981185/ https://www.ncbi.nlm.nih.gov/pubmed/24778878 http://dx.doi.org/10.1155/2014/679605 |
Ejemplares similares
-
Nephrogenic systemic fibrosis
por: Koratala, Abhilash, et al.
Publicado: (2017) -
Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
por: Reiter, Theresa, et al.
Publicado: (2012) -
Nephrogenic systemic fibrosis
por: Braverman, Irwin M, et al.
Publicado: (2010) -
Nephrogenic systemic fibrosis
por: Madke, Bhushan, et al.
Publicado: (2011) -
NEPHROGENIC SYSTEMIC FIBROSIS: CURRENT CONCEPTS
por: Basak, Prasanta, et al.
Publicado: (2011)